These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 30555045
21. Up-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by ß-Klotho. Warsi J, Abousaab A, Lang F. Neurosignals; 2015; 23(1):59-70. PubMed ID: 26684854 [Abstract] [Full Text] [Related]
22. Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia. O'Donovan SM, Hasselfeld K, Bauer D, Simmons M, Roussos P, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE. Transl Psychiatry; 2015 Jun 09; 5(6):e579. PubMed ID: 26057049 [Abstract] [Full Text] [Related]
23. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. Mallolas J, Hurtado O, Castellanos M, Blanco M, Sobrino T, Serena J, Vivancos J, Castillo J, Lizasoain I, Moro MA, Dávalos A. J Exp Med; 2006 Mar 20; 203(3):711-7. PubMed ID: 16520390 [Abstract] [Full Text] [Related]
24. Over-expression of the human EAAT2 glutamate transporter within neurons of mouse organotypic hippocampal slice cultures leads to increased vulnerability of CA1 pyramidal cells. Selkirk JV, Stiefel TH, Stone IM, Naeve GS, Foster AC, Poulsen DJ. Eur J Neurosci; 2005 Apr 20; 21(8):2291-6. PubMed ID: 15869527 [Abstract] [Full Text] [Related]
25. Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2. Hoogland G, Bos IW, Kupper F, van Willigen G, Spierenburg HA, van Nieuwenhuizen O, de Graan PN. Neurochem Int; 2005 Dec 20; 47(7):499-506. PubMed ID: 16137792 [Abstract] [Full Text] [Related]
26. Increased expression and function of glutamate transporters in multiple sclerosis. Vallejo-Illarramendi A, Domercq M, Pérez-Cerdá F, Ravid R, Matute C. Neurobiol Dis; 2006 Jan 20; 21(1):154-64. PubMed ID: 16061389 [Abstract] [Full Text] [Related]
27. Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2. Kortagere S, Mortensen OV, Xia J, Lester W, Fang Y, Srikanth Y, Salvino JM, Fontana ACK. ACS Chem Neurosci; 2018 Mar 21; 9(3):522-534. PubMed ID: 29140675 [Abstract] [Full Text] [Related]
28. WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake. Dunlop J, Eliasof S, Stack G, McIlvain HB, Greenfield A, Kowal D, Petroski R, Carrick T. Br J Pharmacol; 2003 Nov 21; 140(5):839-46. PubMed ID: 14517179 [Abstract] [Full Text] [Related]
29. Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS. van Landeghem FK, Weiss T, von Deimling A. Regul Pept; 2007 Jul 05; 142(1-2):52-9. PubMed ID: 17346813 [Abstract] [Full Text] [Related]
36. Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism. Spangaro M, Bosia M, Bechi M, Buonocore M, Cocchi F, Guglielmino C, Bianchi L, Mastromatteo A, Lorenzi C, Cavallaro R. Schizophr Res; 2018 Dec 05; 202():106-110. PubMed ID: 30539765 [Abstract] [Full Text] [Related]
40. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. Pampliega O, Domercq M, Villoslada P, Sepulcre J, Rodríguez-Antigüedad A, Matute C. J Neuroimmunol; 2008 Mar 05; 195(1-2):194-8. PubMed ID: 18378006 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]